• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

灭活脊髓灰质炎疫苗中的细胞基质与风险。

Cell substrate and risk in killed poliomyelitis vaccine.

作者信息

Horodniceanu F, Crainic R, Barme M

出版信息

Dev Biol Stand. 1981;47:35-9.

PMID:6262159
Abstract

By using 3H-T labeled HeLa cell DNA it was possible to evaluate the quantity and the state of substrate DNA present in crude and purified killed poliovaccine. The results showed that 1.7 x 10(5) pg/ml of DNA is present in crude vaccine while in purified vaccine this product can not be detected (the limit of the detection method was 1.1 x 10(2) pg/ml). The theoretical problems of the risk of the formation of poliovirus pseudotypes and the potential contamination of the vaccine with a type C retrovirus are examined.

摘要

通过使用3H-T标记的HeLa细胞DNA,可以评估粗制和纯化的灭活脊髓灰质炎疫苗中底物DNA的数量和状态。结果表明,粗制疫苗中存在1.7×10⁵ pg/ml的DNA,而在纯化疫苗中无法检测到该产物(检测方法的极限为1.1×10² pg/ml)。研究了脊髓灰质炎病毒假型形成风险以及疫苗被C型逆转录病毒潜在污染的理论问题。

相似文献

1
Cell substrate and risk in killed poliomyelitis vaccine.灭活脊髓灰质炎疫苗中的细胞基质与风险。
Dev Biol Stand. 1981;47:35-9.
2
Presence and quantification of cell substrate DNA in inactivated poliovirus vaccine.灭活脊髓灰质炎疫苗中细胞基质DNA的存在及定量分析
Dev Biol Stand. 1980;46:275-9.
3
Cell substrate for killed poliovaccine production.用于生产灭活脊髓灰质炎疫苗的细胞基质。
Dev Biol Stand. 1981;47:19-23.
4
Quantitation of cell DNA in the evaluation of heteroploid cells as substrate for the preparation of killed viral vaccines.
Intervirology. 1980;14(5-6):300-9. doi: 10.1159/000149200.
5
Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccine.用于制造重组腺相关病毒-艾滋病毒疫苗的基于HeLa细胞的细胞基质的安全性表征。
Vaccine. 2005 Apr 8;23(20):2628-38. doi: 10.1016/j.vaccine.2004.11.027.
6
Thousand litre scale microcarrier culture of Vero cells for killed polio virus vaccine. Promising results.用于灭活脊髓灰质炎病毒疫苗的Vero细胞千升规模微载体培养。结果令人鼓舞。
Dev Biol Stand. 1983;55:37-42.
7
[Use of diploid cell lines as a multiplication substrate for viral vaccine production].
Z Gesamte Hyg. 1980;26(5):365-72.
8
Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.灭活脊髓灰质炎病毒疫苗和口服脊髓灰质炎病毒疫苗序贯接种后减毒脊髓灰质炎病毒5'-非翻译区回复突变的分析
J Infect Dis. 2006 May 15;193(10):1344-9. doi: 10.1086/503366. Epub 2006 Apr 4.
9
Decision analysis in planning for a polio outbreak in the United States.美国脊髓灰质炎疫情应对规划中的决策分析
Pediatrics. 2006 Aug;118(2):611-8. doi: 10.1542/peds.2005-2358.
10
Killed poliovaccine: an evaluation of safety testing.灭活脊髓灰质炎疫苗:安全性测试评估
Dev Biol Stand. 1981;47:143-50.